Glycolysis Define Two Prognostic Subgroups of Lung Adenocarcinoma With Different Mutation Characteristics and Immune Infiltration Signatures

被引:4
|
作者
Huo, Chen [1 ]
Zhang, Meng-Yu [1 ]
Li, Rui [1 ]
Liu, Ting-Ting [1 ]
Li, Jian-Ping [1 ]
Qu, Yi-Qing [2 ]
机构
[1] Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Dept Pulm & Crit Care Med,Shandong Key Lab Infect, Jinan, Peoples R China
[2] Shandong Univ, Qilu Hosp, Dept Pulm & Crit Care Med, Shandong Key Lab Infect Resp Dis, Jinan, Peoples R China
关键词
lung adenocarcinoma; glycolysis; tumor mutational burdens; prognosis; tumor-infiltrating immune cell; INTERACTION NETWORKS; CANCER; TUMORS; INHIBITION; RESISTANCE;
D O I
10.3389/fcell.2021.645482
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Increasing studies have proved that malignant tumors are associated with energy metabolism. This study was aimed to explore biological variables that impact the prognosis of patients in the glycolysis-related subgroups of lung adenocarcinoma (LUAD). The mRNA expression profiling and mutation data in large LUAD samples were collected from the Cancer Genome Atlas (TCGA) database. Then, we identified the expression level and prognostic value of glycolysis-related genes, as well as the fractions of 22 immune cells in the tumor microenvironment. The differences between glycolysis activity, mutation, and immune infiltrates were discussed in these groups, respectively. Two hundred fifty-five glycolysis-related genes were identified from gene set enrichment analysis (GSEA), of which 43 genes had prognostic values (p < 0.05). Next, we constructed a glycolysis-related competing endogenous RNA (ceRNA) network which related to the survival of LUAD. Then, two subgroups of LUAD (clusters 1 and 2) were identified by applying unsupervised consensus clustering to 43 glycolysis-related genes. The survival analysis showed that the cluster 1 patients had a worse prognosis (p < 0.001), and upregulated differentially expressed genes (DEGs) are interestingly enriched in malignancy-related biological processes. The differences between the two subgroups are SPTA1, KEAP1, USH2A, and KRAS among top 10 mutated signatures, which may be the underlying mechanism of grouping. Combined high tumor mutational burden (TMB) with tumor subgroups preferably predicts the prognosis of LUAD patients. The CIBERSORT algorithm results revealed that low TMB samples were concerned with increased infiltration level of memory resting CD4+ T cell (p = 0.03), resting mast cells (p = 0.044), and neutrophils (p = 0.002) in cluster 1 and high TMB samples were concerned with increased infiltration level of memory B cells, plasma cells, CD4 memory-activated T cells, macrophages M1, and activated mast cells in cluster 2, while reduced infiltration of monocytes, resting dendritic cells, and resting mast cells was captured in cluster 2. In conclusion, significant different gene expression characteristics were pooled according to the two subgroups of LUAD. The combination of subgroups, TMB and tumor-infiltrating immune cell signature, might be a novel prognostic biomarker in LUAD.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] Moesin as a prognostic indicator of lung adenocarcinoma improves prognosis by enhancing immune lymphocyte infiltration
    Yan-Qi Li
    Zhi Zheng
    Quan-Xing Liu
    Xiao Lu
    Dong Zhou
    Jiao Zhang
    Hong Zheng
    Ji-Gang Dai
    World Journal of Surgical Oncology, 19
  • [32] Moesin as a prognostic indicator of lung adenocarcinoma improves prognosis by enhancing immune lymphocyte infiltration
    Li, Yan-Qi
    Zheng, Zhi
    Liu, Quan-Xing
    Lu, Xiao
    Zhou, Dong
    Zhang, Jiao
    Zheng, Hong
    Dai, Ji-Gang
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2021, 19 (01)
  • [33] Identification of Prognostic Genes and Immune Landscape Signatures Based on Tumor Microenvironment in Lung Adenocarcinoma
    Han, Pengkai
    Fan, Yunxiu
    Liu, Qiping
    Zhou, Junhao
    DISEASE MARKERS, 2022, 2022
  • [34] Identification and analysis of prognostic immune cell homeostasis characteristics in lung adenocarcinoma
    Sun, Yidan
    Ma, Qianqian
    Chen, Yixun
    Liao, Dongying
    Kong, Fanming
    CLINICAL RESPIRATORY JOURNAL, 2024, 18 (05):
  • [35] Identification of Prognostic and Immune Characteristics of Two Lung Adenocarcinoma Subtypes Based on TRPV Channel Family Genes
    Jiang, Jianhua
    Zheng, Pengchao
    Li, Lei
    JOURNAL OF MEMBRANE BIOLOGY, 2024, 257 (1-2): : 115 - 129
  • [36] Identification of Prognostic and Immune Characteristics of Two Lung Adenocarcinoma Subtypes Based on TRPV Channel Family Genes
    Jianhua Jiang
    Pengchao Zheng
    Lei Li
    The Journal of Membrane Biology, 2024, 257 : 115 - 129
  • [37] Bioinformatics analysis based on DNA methylation data identified in lung adenocarcinoma subgroups with different immune characteristics and clinical outcomes
    Yu, Ruilin
    Huang, Xiaoming
    Lin, Junqi
    Lin, Shaoming
    Shen, Guanle
    Chen, Wenbiao
    JOURNAL OF THORACIC DISEASE, 2023, 15 (04) : 2184 - +
  • [38] Anoikis-related gene signatures predict prognosis of lung adenocarcinoma patients and reveal immune infiltration
    Liu, Zhikang
    Zhang, Min
    Cao, Xiong
    Ma, Minjie
    Han, Biao
    TRANSLATIONAL CANCER RESEARCH, 2024, 13 (04) : 1861 - 1875
  • [39] Construction of immune cell infiltration score model to assess prognostic ability of tumor immune environment in lung adenocarcinoma
    Tian, Jiahui
    Fu, Chunyan
    Peng, Qian
    Yang, Jialu
    Fan, Xiaoxiao
    Zeng, Xuan
    Qing, Weiguo
    Wu, Yi
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2023, 15 (03): : 1730 - +
  • [40] Clinical significance and immune landscape of a novel immune cell infiltration-based prognostic model in lung adenocarcinoma
    Qiu, Lupeng
    Yang, Zizhong
    Jia, Guhe
    Liang, Yanjie
    Du, Sicheng
    Zhang, Jian
    Liu, Minglu
    Zhao, Xiao
    Jiao, Shunchang
    HELIYON, 2024, 10 (12)